Candel Therapeutics, Inc.CADLNASDAQ
Loading
Net Income ContractionContracting
Percentile Rank17
Studio
Year-over-Year Change

Total earnings after all expenses, taxes, and interest

Latest
$-38.18M
↓ 26% vs avg
Percentile
P17
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-30.31M
Historical baseline
PeriodValueYoY Change
2025$-38.18M+30.8%
2024$-55.18M-45.4%
2023$-37.94M-101.9%
2022$-18.79M+48.0%
2021$-36.12M-104.3%
2020$-17.68M-114.6%
2019$-8.24M-